imipramine has been researched along with Nervous System Disorders in 6 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ye, N | 1 |
| Qin, W | 1 |
| Tian, S | 1 |
| Xu, Q | 1 |
| Wold, EA | 1 |
| Zhou, J | 1 |
| Zhen, XC | 1 |
| BAUDIS, P | 1 |
| POROT, M | 1 |
| PASCALIS, G | 1 |
| Tripathi, M | 1 |
| Verma, M | 1 |
| Palit, G | 1 |
| Shanker, K | 1 |
| Kolvin, I | 1 |
| Taunch, J | 1 |
| Currah, J | 1 |
| Garside, RF | 1 |
| Nolan, J | 1 |
| Shaw, WB | 1 |
| Gayford, JJ | 1 |
| Redpath, TH | 1 |
2 reviews available for imipramine and Nervous System Disorders
| Article | Year |
|---|---|
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.
Topics: Allosteric Regulation; Clinical Trials as Topic; Humans; Ligands; Nervous System Diseases; Piperidin | 2020 |
The side-effects of carbamazepine.
Topics: Amitriptyline; Anemia, Aplastic; Carbamazepine; Dibenzazepines; Gastrointestinal Diseases; Humans; I | 1969 |
1 trial available for imipramine and Nervous System Disorders
| Article | Year |
|---|---|
Enuresis: a descriptive analysis and a controlled trial.
Topics: Child; Child Development; Electronics, Medical; Enuresis; Extraversion, Psychological; Family Charac | 1972 |
3 other studies available for imipramine and Nervous System Disorders
| Article | Year |
|---|---|
[ON NEUROLOGIC COMPLICATIONS IN IMIPRAMINE THERAPY].
Topics: Facial Paralysis; Imipramine; Nervous System Diseases; Neurologic Manifestations; Toxicology; Urinat | 1964 |
[Neurological complications during imipramine therapy].
Topics: Basal Ganglia Diseases; Disease; Extrapyramidal Tracts; Imipramine; Nervous System Diseases; Parkins | 1959 |
Antipyrine congeners as antidepressant agents.
Topics: Amphetamine; Animals; Antidepressive Agents; Antipyrine; Behavior, Animal; Female; Imipramine; Letha | 1993 |